A number of studies have demonstrated the possible involvement of altered expression and action of the BDNF/TrkB signaling in the pathogenesis of neurodegenerative diseases, including Alzheimer’s disease (AD). Here, NTRK2 is linked to early-onset autosomal dominant Alzheimer disease.